Bacterial RNA polymerase sigma-containing transcription initiation complex (RNAP-sigma RPi)

The bacterial RNA polymerase (RNAP) sigma-containing transcription initiation complex is the multi-subunit machinery responsible for the first and most regulated step of gene expression in bacteria (Bae et al., 2015, PMID: 26359347). It is composed of the core enzyme (subunits alpha2, beta, beta prime, and omega) and a specialized sigma (σ) factor that directs the enzyme to specific promoter sequences (UniProt P0A8V2, P0A8T7). This complex is essential for bacterial viability as it initiates the synthesis of all RNA species, including mRNA, rRNA, and tRNA (Feklistov et al., 2014, PMID: 24606112). The transition from the initial promoter binding to the formation of a transcriptionally active "open complex" is a critical regulatory checkpoint. Because of its central role and structural divergence from eukaryotic RNA polymerases, it serves as a major target for several classes of potent antibiotics (Villain-Guillot et al., 2007, PMID: 17614605). Rifamycins, such as rifampicin, bind to the beta subunit near the active site to sterically block the growth of the nascent RNA chain (Campbell et al., 2001, PMID: 11260715). Other inhibitors, like fidaxomicin, target the "switch" region to prevent the DNA melting required for initiation (Lin et al., 2018, PMID: 29610477). Clinical challenges include the rapid emergence of resistance through mutations in the rpoB gene and significant drug-drug interactions caused by the induction of metabolic enzymes (StatPearls, NBK557480).

Other names

Bacterial RNA polymerase holoenzymeRNAP-sigma complexTranscription initiation complexRNA polymerase-promoter open complexRPoRNAP-σ complex

Inhibition of bacterial RNA synthesis by either sterically blocking the path of the nascent RNA chain within the RNA exit channel (e.g., rifamycins) or by preventing the transition from the closed to the open promoter complex through binding to the RNAP switch region (e.g., fidaxomicin) (Campbell et al., 2001; Lin et al., 2018).